Achieving timely treatment for early-stage non-small cell lung cancer: Factors associated with delayed surgical resection and proposed quality benchmarks.
Timely care is a key quality indicator. Resection delayed beyond 8 weeks for early-stage non-small cell lung cancer (NSCLC) negatively impacts prognosis, yet diagnosis-to-treatment time has steadily increased. We sought to identify drivers of delayed surgical resection and generate evidence for timeliness metrics for optimal outcomes. We evaluated patient-level factors associated with delayed versus timely surgery (>8 vs ≤8 weeks after diagnosis) for clinical stage I-II NSCLC between 2009 and 2019. Factors were identified by estimating adjusted relative risks (aRRs) and 95% CIs using modified Poisson regression. Time to process-level steps from diagnosis, along with the number and combination of these steps, were examined by timeliness of surgery. Among 2567 patients, 46.0% received timely surgery. Factors associated with delayed surgery included Black (aRR, 1.14; 95% CI, 1.02-1.27) and Asian (aRR, 1.14; 95% CI, 1.00-1.29) race, distance to surgical facility of >50 miles (aRR, 1.23; 95% CI, 1.08-1.40), and greater health care use (≥25 visits, aRR, 1.72; 95% CI, 1.53-1.93). More preoperative steps increased time to surgery, but no individual step drove delays. When performed, preoperative steps occurred within the following intervals in 75% of timely surgery recipients: positron emission tomography-computed tomography: 21 days, biopsy: 20 days, pulmonary function tests: 28 days, and thoracic surgery consult: 30 days. As health system and oncologic care processes grow in complexity, timely treatment warrants greater attention. Our results from an integrated health system indicate several patient- and process-level factors contribute to delays that can be mitigated and offer preliminary benchmarks to promote timely NSCLC management.
Read more